Back to search
Prescribing, Off-Label
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prescribing, Off-Label trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Prescribing, Off-Label trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
It involves collecting safety and efficacy data, under the actual conditions of use of off label and compassionate use medicines in children and adolescents app…
The purpose of this study is to measure the level of medicines found in body fluids such as blood, urine, spinal fluid of children.
This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical o…
The primary objective of this study is to evaluate the safety and tolerability of the dietary supplement, nicotinamide mononucleotide (NMN), in individuals with…
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genom…
This observational study aims to assess the outcomes in patients with advanced treatment refractory cancers with matched molecular/precision therapy as per thei…
This is a phase II therapeutic interventional clinical trial that will evaluate the efficacy, safety, and outcomes of off-label immune checkpoint blockade use a…
Patient-Reported Outcomes (PROs) are patient-centered measures used to assess health status, track changes over time, and evaluate the impact of treatment on th…